Asymmetry Capital Management as of Dec. 31, 2020
Portfolio Holdings for Asymmetry Capital Management
Asymmetry Capital Management holds 33 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Viatris (VTRS) | 9.7 | $21M | 1.1M | 18.74 | |
| Sage Therapeutics (SAGE) | 7.2 | $16M | 182k | 86.51 | |
| Jazz Pharmaceuticals (JAZZ) | 6.8 | $15M | 90k | 165.05 | |
| Insulet Corporation (PODD) | 5.3 | $12M | 46k | 255.63 | |
| Nanostring Technologies (NSTGQ) | 5.3 | $12M | 173k | 66.88 | |
| Kura Oncology (KURA) | 5.2 | $11M | 347k | 32.66 | |
| Guardant Health (GH) | 4.7 | $10M | 79k | 128.88 | |
| Biodesix (BDSX) | 4.4 | $9.7M | 479k | 20.16 | |
| D Fluidigm Corp Del (LAB) | 4.2 | $9.3M | 1.5M | 6.00 | |
| Arcus Biosciences Incorporated (RCUS) | 4.1 | $9.0M | 348k | 25.96 | |
| Arena Pharmaceuticals | 3.5 | $7.8M | 101k | 76.83 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $7.7M | 88k | 87.69 | |
| Codexis (CDXS) | 3.2 | $7.0M | 319k | 21.83 | |
| Avadel Pharmaceuticals Adr | 2.9 | $6.4M | 956k | 6.68 | |
| Pmv Pharmaceuticals (PMVP) | 2.7 | $5.9M | 97k | 61.51 | |
| 10x Genomics Inc Cl A (TXG) | 2.4 | $5.3M | 38k | 141.59 | |
| Burning Rock Biotech Ltd- Adr | 2.3 | $5.0M | 218k | 23.10 | |
| Iteos Therapeutics (ITOS) | 2.1 | $4.7M | 138k | 33.82 | |
| C4 Therapeutics (CCCC) | 2.1 | $4.6M | 139k | 33.13 | |
| Fate Therapeutics (FATE) | 2.1 | $4.6M | 51k | 90.93 | |
| Vistagen Therapeutics | 2.0 | $4.3M | 2.2M | 1.94 | |
| Galecto | 1.9 | $4.2M | 337k | 12.51 | |
| Intra Cellular Therapies (ITCI) | 1.9 | $4.2M | 131k | 31.80 | |
| Bristol-myers Squibb-cvr RTS | 1.6 | $3.6M | 5.2M | 0.69 | |
| Sutro Biopharma (STRO) | 1.6 | $3.4M | 158k | 21.71 | |
| Forte Biosciences | 1.4 | $3.1M | 85k | 36.40 | |
| Nucana Plc- Adr | 1.3 | $2.8M | 614k | 4.49 | |
| Mereo Biopharma Group Plc ads (MREO) | 1.2 | $2.6M | 740k | 3.58 | |
| Oric Pharmaceuticals (ORIC) | 1.0 | $2.3M | 67k | 33.85 | |
| Wave Life Sciences (WVE) | 1.0 | $2.2M | 281k | 7.87 | |
| Novus Therapeutics | 0.6 | $1.2M | 80k | 15.40 | |
| Bcls Acquisition Corp | 0.5 | $993k | 89k | 11.14 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $891k | 47k | 18.99 |
